Home > Boards > US OTC > Biotechs > Revance Therapeutics, Inc. (RVNC)

That's hilarious. (EOM)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Fred Kadiddlehopper Member Profile
 
Followed By 24
Posts 3,479
Boards Moderated 1
Alias Born 09/22/06
160x600 placeholder
Revance to Participate in the Stifel 2019 Healthcare Conference Business Wire - 11/12/2019 4:05:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 11/12/2019 11:28:39 AM
Revance to Participate in the Credit Suisse 28th Annual Healthcare Conference Business Wire - 11/6/2019 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2019 4:23:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2019 4:23:25 PM
Revance Reports Third Quarter 2019 Financial Results, Provides Corporate Update Business Wire - 11/4/2019 4:10:00 PM
Revance Completes Enrollment in ASPEN-1 Phase 3 Pivotal Trial for Cervical Dystonia Business Wire - 11/4/2019 4:05:00 PM
Revance Announces Publication of SAKURA 1 and SAKURA 2 Results in Plastic and Reconstructive Surgery Business Wire - 11/4/2019 8:00:00 AM
Revance to Release Third Quarter 2019 Financial Results on Monday, November 4, 2019 Business Wire - 10/28/2019 4:05:00 PM
Revance to Present Clinical Data Highlighting the Efficacy and Safety of DAXI at the ASDS 2019 Annual Meeting Business Wire - 10/23/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 8:18:44 AM
Revance Appoints Mark J. Foley as President and CEO, Replacing Dan Browne Business Wire - 10/14/2019 8:00:00 AM
Revance Earns Great Place to Work® Certification for Second Year Business Wire - 10/2/2019 4:05:00 PM
Revance to Participate in the 2019 Cantor Global Healthcare Conference Business Wire - 9/25/2019 4:05:00 PM
Revance to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference Business Wire - 9/4/2019 4:05:00 PM
Revance to Participate in the Wells Fargo 14th Annual Healthcare Conference Business Wire - 8/28/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2019 8:23:39 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/12/2019 4:10:23 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 4:18:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2019 4:09:22 PM
Revance Reports Second Quarter 2019 Financial Results, Provides Corporate Update Business Wire - 8/5/2019 4:05:00 PM
Revance to Release Second Quarter 2019 Financial Results on Monday, August 5, 2019 Business Wire - 7/29/2019 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/17/2019 8:05:54 AM
Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors Business Wire - 7/17/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 7:35:43 PM
Fred Kadiddlehopper   Thursday, 10/10/19 09:09:45 AM
Re: mouton29 post# 1201
Post # of 1299 
That's hilarious. (EOM)

The more you know, the less you don't know.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist